Helix BioPharma Corp. (TSE:HBP – Get Free Report) crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of C$0.92 and traded as high as C$0.95. Helix BioPharma shares last traded at C$0.95, with a volume of 2,500 shares.
Helix BioPharma Stock Down 15.8 %
The company has a fifty day moving average of C$0.91 and a two-hundred day moving average of C$0.97. The stock has a market capitalization of C$42.42 million, a price-to-earnings ratio of -0.84 and a beta of -0.84.
About Helix BioPharma
Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.
Further Reading
- Five stocks we like better than Helix BioPharma
- What is a Dividend King?
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- How to Evaluate a Stock Before Buying
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- The 3 Best Retail Stocks to Shop for in August
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Helix BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helix BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
